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 Any procedure with the potential to generate fine-particulate aerosols (e.g., vortexing or sonication 
of specimens in an open tube) should be performed in a biological safety cabinet (BSC).  Use 
sealed centrifuge rotors or sample cups, if available, for centrifugation.  Ideally, rotors and cups 
should be loaded and unloaded in a BSC.  Perform any procedures outside a BSC in a manner that 
minimizes the risk of exposure to an inadvertent sample release. 
 
 After specimens are processed, decontaminate work surfaces and equipment.  Use any EPA-
registered hospital disinfectant.  Follow manufacturer's recommendations for use-dilution (i.e., 
concentration), contact time, and care in handling.   
 
B.  Other specimens (e.g., respiratory secretions, stool, or tissue for procedures 
performed in microbiology or pathology laboratories) 
 
 The following activities may be performed in BSL-2 facilities with standard BSL-2 work practices: 
 
o Pathologic examination and processing of formalin-fixed or otherwise inactivated tissues 
o Molecular analysis of extracted nucleic acid preparations 
o Electron microscopic studies with glutaraldehyde-fixed grids 
o Routine examination of bacterial and mycotic cultures 
o Routine staining and microscopic analysis of fixed smears  
o Final packaging of specimens for transport to diagnostic laboratories for additional testing.  
Specimens should already be in a sealed, decontaminated primary container. 
 
 The following activities involving manipulation of untreated specimens should 
 be performed in BSL-2 facilities and in a Class II BSC: 
 
o Aliquoting and/or diluting specimens 
o Inoculating bacterial or mycological culture media 
o Performing diagnostic tests that do not involve propagation of viral agents in vitro or in vivo  
o Nucleic acid extraction procedures involving untreated specimens 
o Preparation and chemical- or heat-fixing of smears for microscopic analysis 
 
Work surfaces should be decontaminated on completion of work with appropriate disinfectants.  All 
disposable waste should be autoclaved.  
Laboratory workers should wear personal protective equipment (PPE), including disposable gloves 
and laboratory coats.   
Any procedure or process that cannot be conducted in a BSC should be performed while wearing 
gloves, gown, eye protection, and respiratory protection, (see Supplement I, Section III.D.5).   
Acceptable methods of respiratory protection include: a properly fit-tested, NIOSH-approved filter 
respirator (N-95 or higher level) or a powered air-purifying respirator (PAPR) equipped with high-
efficiency particulate air (HEPA) filters.  Accurate fit-testing is a key component of effective 
respirator use.1  Personnel who cannot wear fitted respirators because of facial hair or other fit 
limitations should wear loose-fitting hooded or helmeted PAPRs.   
 
1 Respirators should be used in the context of a complete respiratory protection program, as required by the 
Occupational Safety and Health Administration (OSHA).  This includes training, fit-testing, and fit-checking to ensure 
appropriate respiratory selection and use.  To be effective, respirators must provide a proper sealing surface on the 
wearer’s face.  Detailed information on a respiratory protection program can be found at: 
www.osha.gov/SLTC/etools/respiratory/. 
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Appropriate physical containment devices (e.g., centrifuge safety cups; sealed rotors) should also 
be used.  Ideally, rotors and cups should be loaded and unloaded in a BSC.   
 
 The following activities must be performed in a BSL-3 facility using BSL-3 work practices:   
 
o SARS-CoV propagation in cell culture 
o Initial characterization of viral agents recovered in cultures of SARS specimens 
 
Any procedure or process that cannot be conducted in a BSC should be performed while wearing 
gloves, gown, eye protection, and respiratory protection (see Supplement I, Section III.D.5).   
 
Acceptable methods of respiratory protection include: a properly fit-tested, NIOSH-approved filter 
respirator (N-95 or higher level) or PAPR equipped with HEPA filters.  Accurate fit-testing is a key 
component of effective respirator use.1 Personnel who cannot wear fitted respirators because of 
facial hair or other fit limitations should wear loose-fitting hooded or helmeted PAPRs.   
 
Centrifugation should be carried out using sealed centrifuge cups or rotors that are unloaded in a 
BSC.  
 
 The following activities must be performed in Animal BSL-3 facilities using Animal BSL-3 work 
practices: 
 
o Inoculation of animals for potential recovery of SARS-CoV from SARS samples  
o Protocols involving animal inoculation for characterization of putative SARS agents  
  
Consideration may also be given to referral of specimens to a suitably equipped reference laboratory.  
 
 
Note:  Packaging, shipping, and transport of specimens from possible and known cases of SARS-CoV 
disease must follow the current edition of the International Air Transport Association (IATA) Dangerous 
Goods Regulations at (www.iata.org/dangerousgoods/index) and US DOT 49 CFR Parts 171-180 




For more information, visit www.cdc.gov/ncidod/sars or call the CDC public response hotline 
at (888) 246-2675 (English), (888) 246-2857 (Español), or (866) 874-2646 (TTY) 
                                                                                                                                                          
 
1 Respirators should be used in the context of a complete respiratory protection program, as required by the 
Occupational Safety and Health Administration (OSHA).  This includes training, fit-testing, and fit-checking to ensure 
appropriate respiratory selection and use.  To be effective, respirators must provide a proper sealing surface on the 
wearer’s face.  Detailed information on a respiratory protection program can be found at: 
www.osha.gov/SLTC/etools/respiratory/. 
 
